These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 28102859)

  • 1. Diagnostic Accuracy of Methylated SEPT9 for Blood-based Colorectal Cancer Detection: A Systematic Review and Meta-Analysis.
    Nian J; Sun X; Ming S; Yan C; Ma Y; Feng Y; Yang L; Yu M; Zhang G; Wang X
    Clin Transl Gastroenterol; 2017 Jan; 8(1):e216. PubMed ID: 28102859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic Value and Clinical Significance of Methylated SEPT9 for Colorectal Cancer: A Meta-Analysis.
    Hu J; Hu B; Gui YC; Tan ZB; Xu JW
    Med Sci Monit; 2019 Aug; 25():5813-5822. PubMed ID: 31378778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utility of the methylated SEPT9 test for the early detection of colorectal cancer: a systematic review and meta-analysis of diagnostic test accuracy.
    Hariharan R; Jenkins M
    BMJ Open Gastroenterol; 2020; 7(1):e000355. PubMed ID: 32128229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic Value of Methylated Septin9 for Colorectal Cancer Screening: A Meta-Analysis.
    Yan S; Liu Z; Yu S; Bao Y
    Med Sci Monit; 2016 Sep; 22():3409-3418. PubMed ID: 27665580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening for colon cancer: A test for occult blood.
    Khakimov N; Khasanova G; Ershova K; Gibadullina L; Vetkina T; Lobisheva G; Chumakova A
    Int J Risk Saf Med; 2015; 27 Suppl 1():S110-1. PubMed ID: 26639687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic Value of Methylated
    Xie L; Jiang X; Li Q; Sun Z; Quan W; Duan Y; Li D; Chen T
    Front Oncol; 2018; 8():247. PubMed ID: 30013949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opportunistic screening and survival prediction of digestive cancers by the combination of blood
    Song L; Chen Y; Gong Y; Wan J; Guo S; Liu H; Li Y; Zeng Z; Lu Y
    Ther Adv Med Oncol; 2020; 12():1758835920962966. PubMed ID: 33403008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating microRNA-21 as a potential diagnostic marker for colorectal cancer: A meta-analysis.
    Yu W; Wang Z; Shen LI; Wei Q
    Mol Clin Oncol; 2016 Feb; 4(2):237-244. PubMed ID: 26893868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma Methylated SEPT9 as a Novel Biomarker for Predicting Liver Metastasis in Colorectal Cancer.
    Yu M; Yang C; Wang S; Shi Y; Wang J; Meng C; Xue L; Chen Z
    Mol Biotechnol; 2024 Sep; 66(9):2254-2261. PubMed ID: 37608077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A pooled analysis of the diagnostic efficacy of plasmic methylated septin-9 as a novel biomarker for colorectal cancer.
    Zhang M; He Y; Zhang X; Zhang M; Kong L
    Biomed Rep; 2017 Oct; 7(4):353-360. PubMed ID: 29085631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood leukocytes methylation levels analysis indicate methylated plasma test is a promising tool for colorectal cancer early detection.
    Chen Z; Zhao G; Wang K; Wang X; Ma Y; Xiong S; Zheng M; Fei S
    J Cancer; 2021; 12(12):3678-3685. PubMed ID: 33995643
    [No Abstract]   [Full Text] [Related]  

  • 12. Diagnostic Value of (18)F-FDG PET/CT in Detecting Local Recurrent Colorectal Cancer: A Pooled Analysis of 26 Individual Studies.
    Yu T; Meng N; Chi D; Zhao Y; Wang K; Luo Y
    Cell Biochem Biophys; 2015 Jun; 72(2):443-51. PubMed ID: 25737131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Promising Epigenetic Biomarkers for the Early Detection of Colorectal Cancer: A Systematic Review.
    Anghel SA; Ioniță-Mîndrican CB; Luca I; Pop AL
    Cancers (Basel); 2021 Oct; 13(19):. PubMed ID: 34638449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic value of circulating miR-21 for colorectal cancer: a meta-analysis.
    Shan L; Ji Q; Cheng G; Xia J; Liu D; Wu C; Zhu B; Ding Y
    Cancer Biomark; 2015; 15(1):47-56. PubMed ID: 25524942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The diagnostic value of DNA hypermethylation in stool for colorectal cancer: a meta-analysis.
    Qian LY; Zhang W
    J Cancer Res Ther; 2014 Dec; 10 Suppl():287-91. PubMed ID: 25693937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical performance of an automated stool DNA assay for detection of colorectal neoplasia.
    Lidgard GP; Domanico MJ; Bruinsma JJ; Light J; Gagrat ZD; Oldham-Haltom RL; Fourrier KD; Allawi H; Yab TC; Taylor WR; Simonson JA; Devens M; Heigh RI; Ahlquist DA; Berger BM
    Clin Gastroenterol Hepatol; 2013 Oct; 11(10):1313-8. PubMed ID: 23639600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Innovative Semi-Nested Realtime PCR Assay with Extendable Blocking Probe for Enhanced Analysis of
    Duong LT; Dao TT; Bui HT; Nguyen UD; Hoang UT; Tran DV; Nguyen BV; Ho TH
    Biomedicines; 2024 Jul; 12(7):. PubMed ID: 39062031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating methylated septin 9 nucleic Acid in the plasma of patients with gastrointestinal cancer in the stomach and colon.
    Lee HS; Hwang SM; Kim TS; Kim DW; Park DJ; Kang SB; Kim HH; Park KU
    Transl Oncol; 2013 Jun; 6(3):290-6. PubMed ID: 23730408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood-Based Protein Signatures for Early Detection of Colorectal Cancer: A Systematic Review.
    Bhardwaj M; Gies A; Werner S; Schrotz-King P; Brenner H
    Clin Transl Gastroenterol; 2017 Nov; 8(11):e128. PubMed ID: 29189767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Data mining-based model and risk prediction of colorectal cancer by using secondary health data: A systematic review.
    Liang H; Yang L; Tao L; Shi L; Yang W; Bai J; Zheng D; Wang N; Ji J
    Chin J Cancer Res; 2020 Apr; 32(2):242-251. PubMed ID: 32410801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.